BLEOMYCIN SULFATE - search results

pfizer australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; sulfuric acid - vincristine is used primarily in the treatment of acute leukaemia, usually as a component of various chemotherapeutic regimens. it has also been used as part of combination therapy in the treatment of hodgkin's disease, non-hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, wilm's tumour, osteogenic sarcoma, mycosis fungoides, ewing's sarcoma, carcinoma of the uterine cervix, breast cancer, malignant melanoma, oat-cell carcinoma of the lung and gynaecological tumours of childhood. vincristine may be useful in patients with true idiopathic thrombocytopenic purpura resistant to the usual treatment, but not recommended as primary treatment for this disorder

Australia - English - Department of Health (Therapeutic Goods Administration)

vincristine sulfate injection 2 mg in 2 ml (4)

pfizer (perth) pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; sulfuric acid; water for injections; sodium hydroxide - vincristine is effective in hodgkins disease and other lymphomas. in hodgkins disease it is effective for the advanced stages (iii and iv) when used in the mopp regime (mechlorethamine, oncovin, prednisone, procarbazine). in non-hodgkins lymphomas, vincristine is an important agent, particularly when used with cyclophosphamide, bleomycin, doxorubicin and prednisone. vincristine is also effective in lymphocytic leukemia. beneficial responses have been reported in patients with a variety of other neoplasms, particularly wilms tumour, neuroblastoma, brain tumours, rhabdomyosarcoma and carcinomas of the breast, bladder, and the female and male reproductive systems.

Australia - English - Department of Health (Therapeutic Goods Administration)

vincristine sulfate injection 1 mg in 1 ml (6)

pfizer (perth) pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; sodium hydroxide; sulfuric acid; water for injections - vincristine is effective in hodgkins disease and other lymphomas. in hodgkins disease it is effective for the advanced stages (iii and iv) when used in the mopp regime (mechlorethamine, oncovin, prednisone, procarbazine). in non-hodgkins lymphomas, vincristine is an important agent, particularly when used with cyclophosphamide, bleomycin, doxorubicin and prednisone. vincristine is also effective in lymphocytic leukemia. beneficial responses have been reported in patients with a variety of other neoplasms, particularly wilms tumour, neuroblastoma, brain tumours, rhabdomyosarcoma and carcinomas of the breast, bladder, and the female and male reproductive systems.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cipla bleomycin injection

cipla medpro (pty) ltd - injection - see ingredients - each vial contains bleomycin sulphate 7,5 mg